MX2
Basic information
Region (hg38): 21:41361999-41409393
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 45 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 45 | 5 | 1 |
Variants in MX2
This is a list of pathogenic ClinVar variants found in the MX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-41370109-C-A | Benign (Feb 24, 2021) | |||
21-41376940-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
21-41376981-A-C | not specified | Uncertain significance (Mar 24, 2023) | ||
21-41377001-A-T | not specified | Uncertain significance (Jan 24, 2023) | ||
21-41377150-G-A | not specified | Uncertain significance (May 31, 2023) | ||
21-41377790-G-A | not specified | Uncertain significance (Jun 30, 2023) | ||
21-41377831-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
21-41377886-T-A | not specified | Uncertain significance (Sep 20, 2023) | ||
21-41377906-G-A | not specified | Uncertain significance (Aug 11, 2021) | ||
21-41377912-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
21-41380067-G-A | not specified | Likely benign (Jul 10, 2023) | ||
21-41380130-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
21-41382437-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
21-41382442-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
21-41382469-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
21-41382497-C-T | not specified | Uncertain significance (Apr 27, 2023) | ||
21-41382514-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
21-41382525-G-T | not specified | Uncertain significance (Apr 10, 2023) | ||
21-41382556-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
21-41382560-T-A | not specified | Uncertain significance (Jul 09, 2021) | ||
21-41390574-C-G | not specified | Uncertain significance (Nov 10, 2021) | ||
21-41390601-C-A | not specified | Uncertain significance (Aug 12, 2021) | ||
21-41390634-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
21-41390650-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
21-41390683-C-T | not specified | Uncertain significance (May 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MX2 | protein_coding | protein_coding | ENST00000330714 | 13 | 47448 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.48e-9 | 0.993 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.582 | 393 | 427 | 0.921 | 0.0000251 | 4759 |
Missense in Polyphen | 124 | 162.61 | 0.76256 | 1731 | ||
Synonymous | -0.256 | 175 | 171 | 1.02 | 0.0000113 | 1343 |
Loss of Function | 2.50 | 19 | 34.9 | 0.544 | 0.00000188 | 372 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00120 | 0.00119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000326 | 0.000325 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Interferon-induced dynamin-like GTPase with potent antiviral activity against human immunodeficiency virus type 1 (HIV-1). Acts by targeting the viral capsid and affects the nuclear uptake and/or stability of the HIV-1 replication complex and the subsequent chromosomal integration of the proviral DNA. Exhibits antiviral activity also against simian immunodeficiency virus (SIV-mnd). May play a role in regulating nucleocytoplasmic transport and cell-cycle progression. {ECO:0000269|PubMed:15184662, ECO:0000269|PubMed:24048477, ECO:0000269|PubMed:24055605, ECO:0000269|PubMed:24121441}.;
- Pathway
- Vitamin D Receptor Pathway;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.260
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.56
Haploinsufficiency Scores
- pHI
- 0.0374
- hipred
- N
- hipred_score
- 0.172
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.472
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mx2
- Phenotype
Gene ontology
- Biological process
- mitochondrial fission;dynamin family protein polymerization involved in mitochondrial fission;defense response;response to virus;protein transport;response to interferon-alpha;innate immune response;regulation of nucleocytoplasmic transport;mRNA transport;defense response to virus;regulation of cell cycle;type I interferon signaling pathway;membrane fusion
- Cellular component
- nucleus;nuclear pore;cytoplasm;cytosol;membrane;mitochondrial membrane
- Molecular function
- GTPase activity;protein binding;GTP binding;microtubule binding